DEF 14A

Company

Pelthos Therapeutics Inc.

Filed

November 25, 2025

Period of Report

December 17, 2025

Accession Number

0001753926-25-001827

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →